查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1523169

精準醫療市場報告：2030 年趨勢、預測與競爭分析

Precision Medicine Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

精準醫療趨勢與預測

預計到 2030 年，全球精準醫療市場將達到 1,436 億美元，2024 年至 2030 年複合年成長率為 9.5%。該市場的主要驅動力是對個人化治療的需求不斷成長以及對伴同性診斷和基因檢測的偏好。全球精準醫療市場前景廣闊，腫瘤、罕見疾病、感染疾病、血液疾病市場充滿機會。

精準醫療按細分領域

本研究按類型、適應症、最終用途和地區對全球精準醫療進行了預測。

精準醫療市場洞察

Lucintel 預計抑制劑在預測期內仍將是最大的細分市場。

在該市場中，腫瘤學預計在預測期內仍將是最大的細分市場。

預計在預測期內，北美仍將是最大的地區。

常問問題

Q1.市場規模為：

A1. 到2030年，全球精準醫療市場預計將達到1,436億美元。

Q2.市場成長預測是多少：

A2. 2024年至2030年，全球精準醫療市場預計將以9.5%的複合年成長率成長。

Q3.影響市場成長的主要促進因素是：

A3. 該市場的主要驅動力是對個人化治療的需求不斷成長以及對伴同性診斷和基因檢測的偏好。

Q4.市場的主要細分市場是：

A4. 精準醫療市場前景廣闊，腫瘤學、罕見疾病、感染疾病和血液學市場充滿機會。

Q5.市場的主要企業是：

A5.主要企業如下：

  • Hoffmann-La Roche
  • Novartis
  • Pfizer
  • Bristol Myers Squibb
  • AstraZeneca
  • Gilead Sciences
  • AbbVie
  • Eli Lilly and Company
  • GlaxoSmithKline
  • Sanofi

Q6.未來最大的細分市場是什麼？

A6.Lucintel 預計抑制劑在預測期內仍將是其最大的細分市場。

Q7. 未來五年預計哪些地區的市場成長最大？

A7. 預計北美在預測期內仍將是最大的地區。

Q8. 可以客製化報告嗎？

A8. 是的，Lucintel 提供 10% 的客製化服務，無需額外付費。

目錄

第1章執行摘要

第2章全球精準醫療市場：市場動態

  • 簡介、背景、分類
  • 供應鏈
  • 產業促進因素與挑戰

第3章 2018-2030年市場趨勢及預測分析

  • 宏觀經濟趨勢（2018-2023）與預測（2024-2030）
  • 全球精準醫療市場趨勢（2018-2023）與預測（2024-2030）
  • 按類型分類的全球精準醫療市場
    • 抑制劑
    • 單株抗體
    • 細胞/基因治療
    • 抗病毒藥物/抗逆轉錄病毒藥物
    • 其他
  • 按適應症分類的全球精準醫療市場
    • 瘤
    • 罕見疾病
    • 感染疾病
    • 血液疾病
    • 其他
  • 按最終用途分類的全球精準醫學市場
    • 醫院/診所
    • 居家醫療

第4章 2018-2030年區域市場趨勢及預測分析

  • 全球精準醫療市場區域分佈
  • 北美精準醫療市場
  • 歐洲精準醫療市場
  • 亞太精準醫療市場
  • 其他地區精準醫療市場

第5章 競爭分析

  • 產品系列分析
  • 營運整合
  • 波特五力分析

第6章 成長機會與策略分析

  • 成長機會分析
  • 全球精準醫療市場的新興趨勢
  • 戰略分析
    • 新產品開發
    • 擴大全球精準醫療市場產能
    • 全球精準醫療市場的併購與合資
    • 認證和許可

第7章主要企業概況

  • Hoffmann-La Roche
  • Novartis
  • Pfizer
  • Bristol Myers Squibb
  • AstraZeneca
  • Gilead Sciences
  • AbbVie
  • Eli Lilly and Company
  • GlaxoSmithKline
  • Sanofi
簡介目錄

Precision Medicine Trends and Forecast

The future of the global precision medicine market looks promising with opportunities in the oncology, rare disease, infectious disease, and hematological disorder markets. The global precision medicine market is expected to reach an estimated $143.6 billion by 2030 with a CAGR of 9.5% from 2024 to 2030. The major drivers for this market are increasing demand for personalized treatment and rising preference for companion diagnostics & genetic testing.

A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.

Precision Medicine by Segment

The study includes a forecast for the global precision medicine by type, indication, end use, and region.

Precision Medicine Market by Type [Shipment Analysis by Value from 2018 to 2030]:

  • Inhibitor Drugs
  • Monoclonal Antibodies
  • Cell & Gene Therapy
  • Antiviral & Anti-Retroviral Drugs
  • Others

Precision Medicine Market by Indication [Shipment Analysis by Value from 2018 to 2030]:

  • Oncology
  • Rare Diseases
  • Infectious Diseases
  • Hematological Disorders
  • Others

Precision Medicine Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Hospitals & Clinics
  • Home Care Settings

Precision Medicine Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Precision Medicine Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies precision medicine companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the precision medicine companies profiled in this report include-

  • Hoffmann-La Roche
  • Novartis
  • Pfizer
  • Bristol Myers Squibb
  • AstraZeneca
  • Gilead Sciences
  • AbbVie
  • Eli Lilly and Company
  • GlaxoSmithKline
  • Sanofi

Precision Medicine Market Insights

Lucintel forecasts that inhibitor drug will remain the largest segment over the forecast period.

Within this market, oncology will remain the largest segment over the forecast period.

North America will remain the largest region over the forecast period.

Features of the Global Precision Medicine Market

Market Size Estimates: Precision medicine market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Precision medicine market size by type, indication, end use, and region in terms of value ($B).

Regional Analysis: Precision medicine market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, indications, end uses, and regions for the precision medicine market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the precision medicine market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the precision medicine market size?

Answer: The global precision medicine market is expected to reach an estimated $143.6 billion by 2030.

Q2. What is the growth forecast for precision medicine market?

Answer: The global precision medicine market is expected to grow with a CAGR of 9.5% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the precision medicine market?

Answer: The major drivers for this market are increasing demand for personalized treatment and rising preference for companion diagnostics & genetic testing.

Q4. What are the major segments for precision medicine market?

Answer: The future of the precision medicine market looks promising with opportunities in the oncology, rare disease, infectious disease, and hematological disorder markets.

Q5. Who are the key precision medicine market companies?

Answer: Some of the key precision medicine companies are as follows:

  • Hoffmann-La Roche
  • Novartis
  • Pfizer
  • Bristol Myers Squibb
  • AstraZeneca
  • Gilead Sciences
  • AbbVie
  • Eli Lilly and Company
  • GlaxoSmithKline
  • Sanofi

Q6. Which precision medicine market segment will be the largest in future?

Answer: Lucintel forecasts that inhibitor drug will remain the largest segment over the forecast period.

Q7. In precision medicine market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the precision medicine market by type (inhibitor drugs, monoclonal antibodies, cell & gene therapy, antiviral & anti-retroviral drugs, and others), indication (oncology, rare diseases, infectious diseases, hematological disorders, and others), end use (hospitals & clinics and home care settings), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Precision Medicine Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Precision Medicine Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Precision Medicine Market by Type
    • 3.3.1: Inhibitor Drugs
    • 3.3.2: Monoclonal Antibodies
    • 3.3.3: Cell & Gene Therapy
    • 3.3.4: Antiviral & Anti-Retroviral Drugs
    • 3.3.5: Others
  • 3.4: Global Precision Medicine Market by Indication
    • 3.4.1: Oncology
    • 3.4.2: Rare Diseases
    • 3.4.3: Infectious Diseases
    • 3.4.4: Hematological Disorders
    • 3.4.5: Others
  • 3.5: Global Precision Medicine Market by End Use
    • 3.5.1: Hospitals & Clinics
    • 3.5.2: Home Care Settings

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Precision Medicine Market by Region
  • 4.2: North American Precision Medicine Market
    • 4.2.1: North American Precision Medicine Market by Type: Inhibitor Drugs, Monoclonal Antibodies, Cell & Gene Therapy, Antiviral & Anti-Retroviral Drugs, and Others
    • 4.2.2: North American Precision Medicine Market by Indication: Oncology, Rare Diseases, Infectious Diseases, Hematological Disorders, and Others
  • 4.3: European Precision Medicine Market
    • 4.3.1: European Precision Medicine Market by Type: Inhibitor Drugs, Monoclonal Antibodies, Cell & Gene Therapy, Antiviral & Anti-Retroviral Drugs, and Others
    • 4.3.2: European Precision Medicine Market by Indication: Oncology, Rare Diseases, Infectious Diseases, Hematological Disorders, and Others
  • 4.4: APAC Precision Medicine Market
    • 4.4.1: APAC Precision Medicine Market by Type: Inhibitor Drugs, Monoclonal Antibodies, Cell & Gene Therapy, Antiviral & Anti-Retroviral Drugs, and Others
    • 4.4.2: APAC Precision Medicine Market by Indication: Oncology, Rare Diseases, Infectious Diseases, Hematological Disorders, and Others
  • 4.5: ROW Precision Medicine Market
    • 4.5.1: ROW Precision Medicine Market by Type: Inhibitor Drugs, Monoclonal Antibodies, Cell & Gene Therapy, Antiviral & Anti-Retroviral Drugs, and Others
    • 4.5.2: ROW Precision Medicine Market by Indication: Oncology, Rare Diseases, Infectious Diseases, Hematological Disorders, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Precision Medicine Market by Type
    • 6.1.2: Growth Opportunities for the Global Precision Medicine Market by Indication
    • 6.1.3: Growth Opportunities for the Global Precision Medicine Market by End Use
    • 6.1.4: Growth Opportunities for the Global Precision Medicine Market by Region
  • 6.2: Emerging Trends in the Global Precision Medicine Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Precision Medicine Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Precision Medicine Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Hoffmann-La Roche
  • 7.2: Novartis
  • 7.3: Pfizer
  • 7.4: Bristol Myers Squibb
  • 7.5: AstraZeneca
  • 7.6: Gilead Sciences
  • 7.7: AbbVie
  • 7.8: Eli Lilly and Company
  • 7.9: GlaxoSmithKline
  • 7.10: Sanofi